RELATIVE POTENCY OF PROGESTINS USED IN ORAL-CONTRACEPTIVES

被引：41

作者：

DORFLINGER, LJ

机构：

来源：

关键词：

D O I：

10.1016/0010-7824(85)90056-3

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：557 / 570

页数：14

共 29 条

[1] SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN WOMEN USING ORAL-CONTRACEPTIVES, ESTROGENS AND PROGESTINS
BRADLEY, DD
WINGERD, J
PETITTI, DB
KRAUSS, RM
RAMCHARAN, S
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (01) : 17 - 20
[2] BRIGGS M, 1982, SINGAPORE J OBSTET, V13, P170
[3] BRIGGS MH, 1983, NEW ENGL J MED, V309, P559
[4] BRIGGS MH, 1983, PROGESTOGENS THERAPY
[5] DICKEY RP, 1976, OBSTET GYNECOL, V47, P106
[6] POTENCIES OF ORAL-CONTRACEPTIVES
EDGREN, RA
STURTEVANT, FM
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1976, 125 (08) : 1029 - 1038
[7] EDGREN RA, 1978, INT J FERTIL, V23, P162
[8] FERIN J, 1972, INT ENCY PHARM THERA, P245
[9] GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI
[10] COMPARATIVE STUDIES OF ETHYNYL ESTROGENS USED IN ORAL-CONTRACEPTIVES .1. ENDOMETRIAL RESPONSE
GOLDZIEHER, JW
MAQUEO, M
CHENAULT, CB
WOUTERSZ, TB
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1975, 122 (05) : 615 - 618